Global Astrocytoma Market Size study, and Regional Forecasts 2022-2032

by Type (Anaplastic Astrocytomas, Glioblastomas, Diffuse Astrocytomas, Pineal Astrocytic Tumors, Drain Stem Gliomas, Pilocytic Astrocytomas, Subependymal Giant Cell Astrocytomas), by Treatment (Surgery, Radiation, Chemotherapy), by Application (Pre-registration Phase, Clinical Trial Phase), by End User (Hospitals, Specialty Clinics, Research Centers), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and

Published	Pages	Publisher	Report code
Oct 2024	285	Bizwit Research	ASDR-668128

Published: Oct 2024 - Pages : 285 - Publisher : Bizwit Research - Report code : ASDR-668128

Pfizer Inc.
Genentech Inc.
Novartis AG
Boehringer Ingelheim International GmbH
Amgen Inc.
Celldex Therapeutics
EirGen Pharma
AXELAR
Isarna Therapeutics GmbH
PHARMA’S ALMANAC

Retinoblastoma Treatment Market Size - By Disease Type (Non-hereditary, Hereditary), Disease Stage (Intraocular, Extraocular), Treatment Type (Chemotherapy, Radiation, Surgery, Laser, Cryotherapy), End-user & Global Forecast, 2024 - 2032

This report can be of interest as well:

Retinoblastoma Treatment Market Size - By Disease Type (Non-hereditary, Hereditary), Disease Stage (Intraocular, Extraoc...

Published: December, 2023 | Report code: ASDR-654418